Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Dayi Therapeutics Inc
Profile last edited on: 2/8/2024      CAGE: -----      UEI: EGQ3LAQJS311

Business Identifier: Novel AI driven target discovery and ASO screening platform for monogenic diseases
Year Founded
----
First Award
2023
Latest Award
2023
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

4416 Woodland Ridge Drive
College Station, TX 77845
   N/A
   N/A
   www.dayitherapeutics.com
Location: Single
Congr. District: 10
County: Brazos

Public Profile

Currently there is no description available for this company.

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$299,546
Phase II Dollars
$0
Total Awarded
$299,546

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
0 1 NIH $299,546
Project Title: Developing RNA therapeutics for rare neurodevelopmental disorders

Key People / Management

  Francesco Lotti

Company News

There are no news available.